Kona Medical, Inc., founded in 2009 and privately held, has developed an innovative and non-invasive therapy for the treatment of hypertension (high blood pressure) and other disorders. Kona Medical is based in Bellevue, Washington and is actively supported by leading medical technology investors. The flagship product, the Surround Sound® Hypertension Therapy System provides a one-time, non-invasive therapy for hypertension using ultrasound imaging to robotically guide the delivery of focused ultrasound energy for renal denervation (RDN). The procedure eliminates the need for radiation, contrast media, shielding or the Cath lab and reduces the cost and complexity of other technologies. Clinical trials have shown promise in significantly reducing blood pressure with this simple procedure and also provide an excellent safety profile.
Note: Kona Medical’s technology is investigational and is not yet approved by the US Food and Drug Administration.
Note: Kona Medical’s technology is investigational and is not yet approved by the US Food and Drug Administration.
Location: United States, Washington, Bellevue
Employees: 11-50
Total raised: $80M
Founded date: 2009
Investors 2
| Date | Name | Website |
| - | Domain Ass... | domainvc.c... |
| 14.05.2021 | EW Healthc... | ewhealthca... |
Funding Rounds 3
| Date | Series | Amount | Investors |
| 21.10.2013 | Series D | $10M | - |
| 04.12.2012 | Series C | $40M | - |
| 30.05.2012 | Series C | $30M | - |
Mentions in press and media 13
| Date | Title | Description |
| 23.12.2013 | Deals of the Year: The top 28 venture capital investments we tracked in 2013 | Venture capital investing in Washington state started out with a whimper in 2013, but it is ending with a bang. After the slow start, as evidenced by the chart above from CB Insights in which just $100 million was invested in the first quar... |
| 21.10.2013 | Kona Medical Closes $10M Series D Financing | BELLEVUE, WA, Kona Medical today announced it has closed a Series D equity financing of $10 million led by Morningside Group. >> Click here for more funding data on Kona Medical >> To export Kona Medical funding data to PDF ... |
| 21.10.2013 | Kona Medical raises $10M Series D | Kona Medical said it closed a $10 million Series D round it plans to use to enter the Chinese renal denervation market. Unlike other renal ablation systems, Kona’s Surround Sound device uses external ultrasound to non-invasively target the ... |
| 21.10.2013 | Kona Medical Completes $10M Series D Financing | Kona Medical, a Bellevue, Wash., and Menlo Park, Calif.-based developer of treatments for hypertension, completed a $10m Series D financing round. Morningside Group was the sole investor. The company intends to use the funds for the China m... |
| 04.12.2012 | Kona Medical lands $10M to reduce high blood pressure with ‘Surround Sound’ system | Kona Medical has reeled in another $10 million in equity and debt financing to continue working on a novel method that uses ultrasound to reduce high blood pressure. The financing, provided by two undisclosed strategic investors as well as ... |
| 04.12.2012 | Kona Medical Adds $10M to Close Series C Financing | Kona Medical Inc., a Bellevue, Washington, and Menlo Park, Calif.-based developer of ultrasound technology to treat the nerves leading to and from the kidney, has added $10m in equity and debt financing to close its Series C round. This lat... |
| 04.12.2012 | Funding: Non-invasive renal ablation tech firm Kona Medical closes $40M Series C | Hypertension treatment devices maker Kona Medical closed a Series C funding round totaling $40 million in support of its ultrasound-based renal ablation systems. Unlike other renal ablation systems, Kona’s Surround Sound device uses externa... |
| 04.12.2012 | Kona Medical Adds $10M to Series C Financing | BELLEVUE, WA, Kona Medical today announced it has completed its Series C financing. >> Click here for more funding data on Kona Medical >> To export Kona Medical funding data to PDF and Excel, click here Kona Medical, Inc... |
| 01.06.2012 | Kona Medical Snares $30M Series C | BELLEVUE, WA, The firm raised $30 million in Series C financing to advance its novel hypertension therapy. Existing investors Essex Woodlands, Domain Associates, Morgenthaler Ventures and BioStar Ventures participated. >> Click her... |
| 30.05.2012 | Can ultrasound reduce blood pressure? Kona Medical lands $30M to find out | The Seattle area continues to be a hotbed of innovation in the field of ultrasound technology, with news today that Kona Medical has attracted a $30 million round of venture capital financing. The Bellevue company, which is developing metho... |
Show more